Cybin Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.75

+0.24 (+5.32%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +104.6% upside

Low Target $6.32

Average Target $9.72

High Target $10.76

Current Price $4.75

Current
$4.75

Target
$9.72

$6.32 $9.72 avg $10.76

Scenario Analysis

Bear Case

$6.32

33.1%

Low target

Base Case

$9.72

+104.6%

Avg target

Bull Case

$10.76

+126.5%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$12.70

-62.6% from high

52-Week Low

$6.20

+-23.4% from low

Target vs 52W High

$9.72

-23.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%